This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Aug 1;41(22):3874-3875.

doi: 10.1200/JCO.23.00794. Epub 2023 May 31.

Reply to E. Hindié

Hannah D McManus¹, Andrew J Armstrong¹

Affiliations

Affiliation

¹ Hannah D. McManus, MD and Andrew J. Armstrong, MD, ScM, FACP, Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC.

PMID: 37257141
DOI: 10.1200/JCO.23.00794

Comment

Reply to E. Hindié

Hannah D McManus et al. J Clin Oncol. 2023.

. 2023 Aug 1;41(22):3874-3875.

doi: 10.1200/JCO.23.00794. Epub 2023 May 31.

Authors

Hannah D McManus¹, Andrew J Armstrong¹

Affiliation

¹ Hannah D. McManus, MD and Andrew J. Armstrong, MD, ScM, FACP, Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC.

PMID: 37257141
DOI: 10.1200/JCO.23.00794

No abstract available

PubMed Disclaimer

Comment on

Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
Hindié E. Hindié E. J Clin Oncol. 2023 Aug 1;41(22):3873-3874. doi: 10.1200/JCO.23.00686. Epub 2023 May 31. J Clin Oncol. 2023. PMID: 37257146 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.